Issue 6/2011
Content (10 Articles)
Budget impact analysis in economic evaluation: a proposal for a clearer definition
Livio Garattini, Katelijne van de Vooren
Comparison of cost-weights scales methodologies in the perspective of a financing system based on pathologies
M. Pirson, C. Delo, D. Martins, P. Leclercq
Cost efficiency of university hospitals in the Nordic countries: a cross-country analysis
Emma Medin, Kjartan S. Anthun, Unto Häkkinen, Sverre A. C. Kittelsen, Miika Linna, Jon Magnussen, Kim Olsen, Clas Rehnberg
Direct costs of Alzheimer’s disease in Germany
Peter Kiencke, Dietmar Daniel, Christine Grimm, Reinhard Rychlik
Exploring the relationship between costs and quality: Does the joint evaluation of costs and quality alter the ranking of Danish hospital departments?
Anne Hvenegaard, Jacob Nielsen Arendt, Andrew Street, Dorte Gyrd-Hansen
How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives
Özden Gür Ali, Başak Topaler
The impact of repeated cost containment policies on pharmaceutical expenditure: experience in Spain
Iván Moreno-Torres, Jaume Puig-Junoy, Josep M. Raya
Cost-effectiveness of zoledronic acid in the prevention of skeletal-related events in patients with bone metastases secondary to advanced renal cell carcinoma: application to France, Germany, and the United Kingdom
M. F. Botteman, M. Meijboom, I. Foley, J. M. Stephens, Y. M. Chen, S. Kaura
Market structure and hospital–insurer bargaining in the Netherlands
R. S. Halbersma, M. C. Mikkers, E. Motchenkova, I. Seinen